Name | Number of supported studies | Average coverage | |
---|---|---|---|
platelet | 5 studies | 25% ± 4% | |
megakaryocyte | 3 studies | 45% ± 10% | |
erythrocyte | 3 studies | 41% ± 12% |
Insufficient scRNA-seq data for expression of GFI1B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 107.10 | 564 / 578 | 3% | 0.26 | 35 / 1155 |
spleen | 100% | 153.49 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 552.70 | 891 / 929 | 0% | 0 | 0 / 0 |
bladder | 86% | 12.33 | 18 / 21 | 2% | 0.10 | 11 / 504 |
prostate | 74% | 15.90 | 182 / 245 | 0% | 0 | 0 / 502 |
intestine | 65% | 29.72 | 627 / 966 | 3% | 0.12 | 18 / 527 |
heart | 64% | 11.72 | 551 / 861 | 0% | 0 | 0 / 0 |
stomach | 49% | 7.80 | 176 / 359 | 8% | 0.35 | 24 / 286 |
brain | 51% | 7.04 | 1337 / 2642 | 7% | 0.12 | 46 / 705 |
esophagus | 50% | 8.65 | 724 / 1445 | 3% | 0.05 | 6 / 183 |
uterus | 46% | 8.41 | 79 / 170 | 3% | 0.21 | 14 / 459 |
pancreas | 40% | 5.77 | 131 / 328 | 4% | 0.06 | 8 / 178 |
adipose | 43% | 6.23 | 523 / 1204 | 0% | 0 | 0 / 0 |
skin | 40% | 5.96 | 729 / 1809 | 2% | 0.03 | 8 / 472 |
kidney | 38% | 5.78 | 34 / 89 | 1% | 0.02 | 6 / 901 |
liver | 37% | 7.08 | 84 / 226 | 0% | 0.01 | 2 / 406 |
thymus | 32% | 4.01 | 207 / 653 | 2% | 0.40 | 10 / 605 |
ovary | 29% | 3.76 | 53 / 180 | 0% | 0.01 | 2 / 430 |
breast | 29% | 3.95 | 133 / 459 | 0% | 0.03 | 5 / 1118 |
adrenal gland | 16% | 1.57 | 41 / 258 | 2% | 0.03 | 4 / 230 |
blood vessel | 17% | 2.02 | 232 / 1335 | 0% | 0 | 0 / 0 |
muscle | 9% | 1.11 | 74 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.12 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_1903706 | Biological process | regulation of hemopoiesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GFI1B |
Protein name | Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML) Growth factor independent 1B transcriptional repressor Growth factor independent 1B (Potential regulator of CDKN1A, translocated in CML), isoform CRA_a (Growth factor independent 1B transcriptional repressor) |
Synonyms | hCG_31457 |
Description | FUNCTION: Essential proto-oncogenic transcriptional regulator necessary for development and differentiation of erythroid and megakaryocytic lineages. Component of a RCOR-GFI-KDM1A-HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development and controls hematopoietic differentiation. Transcriptional repressor or activator depending on both promoter and cell type context; represses promoter activity of SOCS1 and SOCS3 and thus, may regulate cytokine signaling pathways. Cooperates with GATA1 to repress target gene transcription, such as the apoptosis regulator BCL2L1; GFI1B silencing in leukemic cell lines markedly increase apoptosis rate. Inhibits down-regulation of MYC and MYB as well as the cyclin-dependent kinase inhibitor CDKN1A/P21WAF1 in IL6-treated myelomonocytic cells. Represses expression of GATA3 in T-cell lymphomas and inhibits GATA1-mediated transcription; as GATA1 also mediates erythroid GFI1B transcription, both GATA1 and GFI1B participate in a feedback regulatory pathway controlling the expression of GFI1B gene in erythroid cells. Suppresses GATA1-mediated stimulation of GFI1B promoter through protein interaction. Binds to gamma-satellite DNA and to its own promoter, auto-repressing its own expression. Alters histone methylation by recruiting histone methyltransferase to target genes promoters. Plays a role in heterochromatin formation. . |
Accessions | ENST00000372123.5 [Q5VTD9-2] Q5VTD9 A0A024R8F3 ENST00000372122.4 [Q5VTD9-1] ENST00000339463.7 [Q5VTD9-1] ENST00000636137.1 A0A1B0GTD0 ENST00000636263.1 |